Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes. | Acta Haematol;87 Suppl 1: 20-4, 1992. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes.

Adamson, J W; Schuster, M; Allen, S; Haley, N R.

Affiliation

Adamson JW; New York Blood Center, N.Y.

Acta Haematol ; 87 Suppl 1: 20-4, 1992.

Article in En | MEDLINE | ID: mdl-1574963

Subject(s)

Anemia/drug therapy; Erythropoietin/therapeutic use; Myelodysplastic Syndromes/complications; Recombinant Proteins/therapeutic use; Anemia/blood; Anemia/etiology; Blood Transfusion; Hematocrit; Humans; Myelodysplastic Syndromes/blood; Receptors, Transferrin/metabolism

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Recombinant Proteins / Erythropoietin / Anemia Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Acta Haematol Year: 1992 Document type: Article Country of publication: Switzerland

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Recombinant Proteins / Erythropoietin / Anemia Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Acta Haematol Year: 1992 Document type: Article Country of publication: Switzerland